APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Needle-Free Injection Device

Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.

Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.

Selected research

Market Outlook & Growth Opportunities

Global Needle-Free Injection Device Market Outlook and Growth Opportunities 2026

Report ID 173916150421 December 2025197 pages

Choose your research edition.

Industry ResearchNeedle-Free Injection Device Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Needle-Free Injection Device Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Needle-Free Injection Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Needle-Free Injection Device Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Needle-Free Injection Device Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.

Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.

Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.

Read the full market overview

This report provides an overview of the global Needle-Free Injection Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Needle-Free Injection Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Needle-Free Injection Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Needle-Free Injection Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Needle-Free Injection Device Segment by Company

Zogenix

Inovio

Glide Pharma

Akra Dermojet

Crossject Medical Technology

Injex Pharma

Eternity Healthcare

Antares Pharma

Valeritas

Medical International Technologies

Penjet

PharmaJet

National Medical Products

Activa Brand Products

Needle-Free Injection Device Segment by Type

Powder Injections

Liquid Injections

Depot or Projectile Injection

Needle-Free Injection Device Segment by Application

Drug Injection

Cosmetic Surgery Use

Other

Needle-Free Injection Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Needle-Free Injection Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Needle-Free Injection Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Needle-Free Injection Device significant trends, drivers, influence factors in global and regions.

6. To analyze Needle-Free Injection Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-Free Injection Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Needle-Free Injection Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-Free Injection Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Needle-Free Injection Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Needle-Free Injection Device industry.

Chapter 3: Detailed analysis of Needle-Free Injection Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Needle-Free Injection Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Needle-Free Injection Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Needle-Free Injection Device Industry Trends Table 2. Needle-Free Injection Device Industry Drivers Table 3. Needle-Free Injection Device Industry Opportunities and Challenges Table 4. Needle-Free Injection Device Industry Restraints Table 5. Global Needle-Free Injection Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Needle-Free Injection Device Revenue Share by Company (2021-2026) Table 7. Global Needle-Free Injection Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Needle-Free Injection Device Sales Volume Share by Company (2021-2026) Table 9. Global Needle-Free Injection Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Needle-Free Injection Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Needle-Free Injection Device Key Company Manufacturing Base & Headquarters Table 12. Global Needle-Free Injection Device Company, Product Type & Application Table 13. Global Needle-Free Injection Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Needle-Free Injection Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Powder Injections Table 18. Significant Companies of Liquid Injections Table 19. Significant Companies of Depot or Projectile Injection Table 20. Global Needle-Free Injection Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Needle-Free Injection Device Sales Volume by Type (2021-2026) & (k units) Table 22. Global Needle-Free Injection Device Sales Volume by Type (2027-2032) & (k units) Table 23. Global Needle-Free Injection Device Sales Volume Share by Type (2021-2026) Table 24. Global Needle-Free Injection Device Sales Volume Share by Type (2027-2032) Table 25. Global Needle-Free Injection Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Needle-Free Injection Device Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Needle-Free Injection Device Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Needle-Free Injection Device Sales Value Share by Type (2021-2026) Table 29. Global Needle-Free Injection Device Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Drug Injection Table 31. Significant Companies of Cosmetic Surgery Use Table 32. Significant Companies of Other Table 33. Global Needle-Free Injection Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Needle-Free Injection Device Sales Volume by Application (2021-2026) & (k units) Table 35. Global Needle-Free Injection Device Sales Volume by Application (2027-2032) & (k units) Table 36. Global Needle-Free Injection Device Sales Volume Share by Application (2021-2026) Table 37. Global Needle-Free Injection Device Sales Volume Share by Application (2027-2032) Table 38. Global Needle-Free Injection Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Needle-Free Injection Device Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Needle-Free Injection Device Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Needle-Free Injection Device Sales Value Share by Application (2021-2026) Table 42. Global Needle-Free Injection Device Sales Value Share by Application (2027-2032) Table 43. Global Needle-Free Injection Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Needle-Free Injection Device Sales by Region (2021-2026) & (k units) Table 45. Global Needle-Free Injection Device Sales Market Share by Region (2021-2026) Table 46. Global Needle-Free Injection Device Sales by Region (2027-2032) & (k units) Table 47. Global Needle-Free Injection Device Sales Market Share by Region (2027-2032) Table 48. Global Needle-Free Injection Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Needle-Free Injection Device Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Needle-Free Injection Device Sales Value Share by Region (2021-2026) Table 51. Global Needle-Free Injection Device Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Needle-Free Injection Device Sales Value Share by Region (2027-2032) Table 53. Global Needle-Free Injection Device Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Needle-Free Injection Device Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Needle-Free Injection Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Needle-Free Injection Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Needle-Free Injection Device Sales by Country (2021-2026) & (k units) Table 58. Global Needle-Free Injection Device Sales Market Share by Country (2021-2026) Table 59. Global Needle-Free Injection Device Sales by Country (2027-2032) & (k units) Table 60. Global Needle-Free Injection Device Sales Market Share by Country (2027-2032) Table 61. Global Needle-Free Injection Device Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Needle-Free Injection Device Sales Value Market Share by Country (2021-2026) Table 63. Global Needle-Free Injection Device Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Needle-Free Injection Device Sales Value Market Share by Country (2027-2032) Table 65. Zogenix Company Information Table 66. Zogenix Business Overview Table 67. Zogenix Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Zogenix Needle-Free Injection Device Product Portfolio Table 69. Zogenix Recent Development Table 70. Inovio Company Information Table 71. Inovio Business Overview Table 72. Inovio Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Inovio Needle-Free Injection Device Product Portfolio Table 74. Inovio Recent Development Table 75. Glide Pharma Company Information Table 76. Glide Pharma Business Overview Table 77. Glide Pharma Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Glide Pharma Needle-Free Injection Device Product Portfolio Table 79. Glide Pharma Recent Development Table 80. Akra Dermojet Company Information Table 81. Akra Dermojet Business Overview Table 82. Akra Dermojet Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Akra Dermojet Needle-Free Injection Device Product Portfolio Table 84. Akra Dermojet Recent Development Table 85. Crossject Medical Technology Company Information Table 86. Crossject Medical Technology Business Overview Table 87. Crossject Medical Technology Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Crossject Medical Technology Needle-Free Injection Device Product Portfolio Table 89. Crossject Medical Technology Recent Development Table 90. Injex Pharma Company Information Table 91. Injex Pharma Business Overview Table 92. Injex Pharma Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Injex Pharma Needle-Free Injection Device Product Portfolio Table 94. Injex Pharma Recent Development Table 95. Eternity Healthcare Company Information Table 96. Eternity Healthcare Business Overview Table 97. Eternity Healthcare Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Eternity Healthcare Needle-Free Injection Device Product Portfolio Table 99. Eternity Healthcare Recent Development Table 100. Antares Pharma Company Information Table 101. Antares Pharma Business Overview Table 102. Antares Pharma Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Antares Pharma Needle-Free Injection Device Product Portfolio Table 104. Antares Pharma Recent Development Table 105. Valeritas Company Information Table 106. Valeritas Business Overview Table 107. Valeritas Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Valeritas Needle-Free Injection Device Product Portfolio Table 109. Valeritas Recent Development Table 110. Medical International Technologies Company Information Table 111. Medical International Technologies Business Overview Table 112. Medical International Technologies Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Medical International Technologies Needle-Free Injection Device Product Portfolio Table 114. Medical International Technologies Recent Development Table 115. Penjet Company Information Table 116. Penjet Business Overview Table 117. Penjet Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Penjet Needle-Free Injection Device Product Portfolio Table 119. Penjet Recent Development Table 120. PharmaJet Company Information Table 121. PharmaJet Business Overview Table 122. PharmaJet Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. PharmaJet Needle-Free Injection Device Product Portfolio Table 124. PharmaJet Recent Development Table 125. National Medical Products Company Information Table 126. National Medical Products Business Overview Table 127. National Medical Products Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. National Medical Products Needle-Free Injection Device Product Portfolio Table 129. National Medical Products Recent Development Table 130. Activa Brand Products Company Information Table 131. Activa Brand Products Business Overview Table 132. Activa Brand Products Needle-Free Injection Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Activa Brand Products Needle-Free Injection Device Product Portfolio Table 134. Activa Brand Products Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Needle-Free Injection Device Distributors List Table 138. Needle-Free Injection Device Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Needle-Free Injection Device Product Image Figure 2. Global Needle-Free Injection Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Needle-Free Injection Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Needle-Free Injection Device Sales (2021-2032) & (k units) Figure 5. Global Needle-Free Injection Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Needle-Free Injection Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Powder Injections Image Figure 10. Liquid Injections Image Figure 11. Depot or Projectile Injection Image Figure 12. Global Needle-Free Injection Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Needle-Free Injection Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Needle-Free Injection Device Sales Volume Share by Type (2021-2032) Figure 15. Global Needle-Free Injection Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Needle-Free Injection Device Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Needle-Free Injection Device Sales Value Share by Type (2021-2032) Figure 18. Drug Injection Image Figure 19. Cosmetic Surgery Use Image Figure 20. Other Image Figure 21. Global Needle-Free Injection Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Needle-Free Injection Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Needle-Free Injection Device Sales Volume Share by Application (2021-2032) Figure 24. Global Needle-Free Injection Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Needle-Free Injection Device Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Needle-Free Injection Device Sales Value Share by Application (2021-2032) Figure 27. Global Needle-Free Injection Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Needle-Free Injection Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Needle-Free Injection Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Needle-Free Injection Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Needle-Free Injection Device Sales Value (2021-2032) & (US$ Million) Figure 32. North America Needle-Free Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Needle-Free Injection Device Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Needle-Free Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Needle-Free Injection Device Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Needle-Free Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Needle-Free Injection Device Sales Value (2021-2032) & (US$ Million) Figure 38. South America Needle-Free Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Needle-Free Injection Device Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Needle-Free Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Needle-Free Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Needle-Free Injection Device Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Needle-Free Injection Device Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Powder Injections
  • Liquid Injections
  • Depot or Projectile Injection
Applications
  • Drug Injection
  • Cosmetic Surgery Use
  • Other
Companies covered
  • Zogenix
  • Inovio
  • Glide Pharma
  • Akra Dermojet
  • Crossject Medical Technology
  • Injex Pharma
  • Eternity Healthcare
  • Antares Pharma
  • Valeritas
  • Medical International Technologies
  • Penjet
  • PharmaJet
  • National Medical Products
  • Activa Brand Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Needle-Free Injection Device Sales Value (2021-2032)
  4. 1.2.2 Global Needle-Free Injection Device Sales Volume (2021-2032)
  5. 1.2.3 Global Needle-Free Injection Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Needle-Free Injection Device Market Dynamics
  1. 2.1 Needle-Free Injection Device Industry Trends
  2. 2.2 Needle-Free Injection Device Industry Drivers
  3. 2.3 Needle-Free Injection Device Industry Opportunities and Challenges
  4. 2.4 Needle-Free Injection Device Industry Restraints
3 Needle-Free Injection Device Market by Company
  1. 3.1 Global Needle-Free Injection Device Company Revenue Ranking in 2025
  2. 3.2 Global Needle-Free Injection Device Revenue by Company (2021-2026)
  3. 3.3 Global Needle-Free Injection Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Needle-Free Injection Device Average Price by Company (2021-2026)
  5. 3.5 Global Needle-Free Injection Device Company Ranking (2024-2026)
  6. 3.6 Global Needle-Free Injection Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Needle-Free Injection Device Company Product Type and Application
  8. 3.8 Global Needle-Free Injection Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Needle-Free Injection Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Needle-Free Injection Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Needle-Free Injection Device Market by Type
  1. 4.1 Needle-Free Injection Device Type Introduction
  2. 4.1.1 Powder Injections
  3. 4.1.2 Liquid Injections
  4. 4.1.3 Depot or Projectile Injection
  5. 4.2 Global Needle-Free Injection Device Sales Volume by Type
  6. 4.2.1 Global Needle-Free Injection Device Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Needle-Free Injection Device Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Needle-Free Injection Device Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Needle-Free Injection Device Sales Value by Type
  10. 4.3.1 Global Needle-Free Injection Device Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Needle-Free Injection Device Sales Value by Type (2021-2032)
  12. 4.3.3 Global Needle-Free Injection Device Sales Value Share by Type (2021-2032)
5 Needle-Free Injection Device Market by Application
  1. 5.1 Needle-Free Injection Device Application Introduction
  2. 5.1.1 Drug Injection
  3. 5.1.2 Cosmetic Surgery Use
  4. 5.1.3 Other
  5. 5.2 Global Needle-Free Injection Device Sales Volume by Application
  6. 5.2.1 Global Needle-Free Injection Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Needle-Free Injection Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Needle-Free Injection Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Needle-Free Injection Device Sales Value by Application
  10. 5.3.1 Global Needle-Free Injection Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Needle-Free Injection Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Needle-Free Injection Device Sales Value Share by Application (2021-2032)
6 Needle-Free Injection Device Regional Sales and Value Analysis
  1. 6.1 Global Needle-Free Injection Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Needle-Free Injection Device Sales by Region (2021-2032)
  3. 6.2.1 Global Needle-Free Injection Device Sales by Region: 2021-2026
  4. 6.2.2 Global Needle-Free Injection Device Sales by Region (2027-2032)
  5. 6.3 Global Needle-Free Injection Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Needle-Free Injection Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Needle-Free Injection Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Needle-Free Injection Device Sales Value by Region (2027-2032)
  9. 6.5 Global Needle-Free Injection Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Needle-Free Injection Device Sales Value (2021-2032)
  12. 6.6.2 North America Needle-Free Injection Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Needle-Free Injection Device Sales Value (2021-2032)
  15. 6.7.2 Europe Needle-Free Injection Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Needle-Free Injection Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Needle-Free Injection Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Needle-Free Injection Device Sales Value (2021-2032)
  21. 6.9.2 South America Needle-Free Injection Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Needle-Free Injection Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Needle-Free Injection Device Sales Value Share by Country, 2025 VS 2032
7 Needle-Free Injection Device Country-level Sales and Value Analysis
  1. 7.1 Global Needle-Free Injection Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Needle-Free Injection Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Needle-Free Injection Device Sales by Country (2021-2032)
  4. 7.3.1 Global Needle-Free Injection Device Sales by Country (2021-2026)
  5. 7.3.2 Global Needle-Free Injection Device Sales by Country (2027-2032)
  6. 7.4 Global Needle-Free Injection Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Needle-Free Injection Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Needle-Free Injection Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Needle-Free Injection Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Needle-Free Injection Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Needle-Free Injection Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zogenix
  2. 8.1.1 Zogenix Company Information
  3. 8.1.2 Zogenix Business Overview
  4. 8.1.3 Zogenix Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zogenix Needle-Free Injection Device Product Portfolio
  6. 8.1.5 Zogenix Recent Developments
  7. 8.2 Inovio
  8. 8.2.1 Inovio Company Information
  9. 8.2.2 Inovio Business Overview
  10. 8.2.3 Inovio Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Inovio Needle-Free Injection Device Product Portfolio
  12. 8.2.5 Inovio Recent Developments
  13. 8.3 Glide Pharma
  14. 8.3.1 Glide Pharma Company Information
  15. 8.3.2 Glide Pharma Business Overview
  16. 8.3.3 Glide Pharma Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Glide Pharma Needle-Free Injection Device Product Portfolio
  18. 8.3.5 Glide Pharma Recent Developments
  19. 8.4 Akra Dermojet
  20. 8.4.1 Akra Dermojet Company Information
  21. 8.4.2 Akra Dermojet Business Overview
  22. 8.4.3 Akra Dermojet Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Akra Dermojet Needle-Free Injection Device Product Portfolio
  24. 8.4.5 Akra Dermojet Recent Developments
  25. 8.5 Crossject Medical Technology
  26. 8.5.1 Crossject Medical Technology Company Information
  27. 8.5.2 Crossject Medical Technology Business Overview
  28. 8.5.3 Crossject Medical Technology Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Crossject Medical Technology Needle-Free Injection Device Product Portfolio
  30. 8.5.5 Crossject Medical Technology Recent Developments
  31. 8.6 Injex Pharma
  32. 8.6.1 Injex Pharma Company Information
  33. 8.6.2 Injex Pharma Business Overview
  34. 8.6.3 Injex Pharma Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Injex Pharma Needle-Free Injection Device Product Portfolio
  36. 8.6.5 Injex Pharma Recent Developments
  37. 8.7 Eternity Healthcare
  38. 8.7.1 Eternity Healthcare Company Information
  39. 8.7.2 Eternity Healthcare Business Overview
  40. 8.7.3 Eternity Healthcare Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Eternity Healthcare Needle-Free Injection Device Product Portfolio
  42. 8.7.5 Eternity Healthcare Recent Developments
  43. 8.8 Antares Pharma
  44. 8.8.1 Antares Pharma Company Information
  45. 8.8.2 Antares Pharma Business Overview
  46. 8.8.3 Antares Pharma Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Antares Pharma Needle-Free Injection Device Product Portfolio
  48. 8.8.5 Antares Pharma Recent Developments
  49. 8.9 Valeritas
  50. 8.9.1 Valeritas Company Information
  51. 8.9.2 Valeritas Business Overview
  52. 8.9.3 Valeritas Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Valeritas Needle-Free Injection Device Product Portfolio
  54. 8.9.5 Valeritas Recent Developments
  55. 8.10 Medical International Technologies
  56. 8.10.1 Medical International Technologies Company Information
  57. 8.10.2 Medical International Technologies Business Overview
  58. 8.10.3 Medical International Technologies Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Medical International Technologies Needle-Free Injection Device Product Portfolio
  60. 8.10.5 Medical International Technologies Recent Developments
  61. 8.11 Penjet
  62. 8.11.1 Penjet Company Information
  63. 8.11.2 Penjet Business Overview
  64. 8.11.3 Penjet Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Penjet Needle-Free Injection Device Product Portfolio
  66. 8.11.5 Penjet Recent Developments
  67. 8.12 PharmaJet
  68. 8.12.1 PharmaJet Company Information
  69. 8.12.2 PharmaJet Business Overview
  70. 8.12.3 PharmaJet Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 PharmaJet Needle-Free Injection Device Product Portfolio
  72. 8.12.5 PharmaJet Recent Developments
  73. 8.13 National Medical Products
  74. 8.13.1 National Medical Products Company Information
  75. 8.13.2 National Medical Products Business Overview
  76. 8.13.3 National Medical Products Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 National Medical Products Needle-Free Injection Device Product Portfolio
  78. 8.13.5 National Medical Products Recent Developments
  79. 8.14 Activa Brand Products
  80. 8.14.1 Activa Brand Products Company Information
  81. 8.14.2 Activa Brand Products Business Overview
  82. 8.14.3 Activa Brand Products Needle-Free Injection Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Activa Brand Products Needle-Free Injection Device Product Portfolio
  84. 8.14.5 Activa Brand Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Needle-Free Injection Device Value Chain Analysis
  2. 9.1.1 Needle-Free Injection Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Needle-Free Injection Device Sales Mode & Process
  6. 9.2 Needle-Free Injection Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Needle-Free Injection Device Distributors
  9. 9.2.3 Needle-Free Injection Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst